Answers are grounded in this paper and cite their sources.
This study was the first one to directly explore the differential response of arterial VSMCs and venous VSMCs to uremic serum exposure side by side. Both similarities and differences were detected in this in vitro study, which provides insight into the clinical manifestations we observed in patients with ESKD. Furthermore, these results may also be valuable information for uremia-specific therapies for both vascular access dysfunction and CVD/PAD in patients with ESKD.
No takes yet. Share an insight, caveat, or question.
Su et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: